CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 15 enrolled
Drug / intervention
Deoxycholic Aciddrug
Likely dose
Deoxycholic Acid 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04054011
NCT04054011Early Ph 1Completed
CompareCT.gov

Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat

University of California, San Diego·interventional·Posted Aug 13, 2019·Updated Jan 20, 2021

In Brief

A Early Phase 1 clinical trial evaluating Deoxycholic Acid for Adiposity. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This is a phase I, open-label clinical trial evaluating the safety and efficacy of deoxycholic acid injection for reduction of upper inner thigh fat.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdiposity
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedAug 13, 2019
Enrollment StartJul 5, 2019
Primary CompletionMay 19, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.9 years ago

Interventions

Deoxycholic Aciddrug

Deoxycholic acid (Kybella) 10 mg/ mL subcutaneous